Christopher Semko
68Patents
13h-index
72Co-inventors
87Inventor score
Filing activity: Jun 6, 1995 → Jul 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7049306B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. | Emerging Cross-Sectional Technologies | 70 | Expired |
| US7026328B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 29 | Expired |
| US6583139B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 29 | Expired |
| US7008949B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Human Necessities | 28 | Expired |
| US6492421B1 | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 26 | Expired |
| US6492372B1 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6479492B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6903088B2 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7135477B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 15 | Expired |
| US6689781B2 | Phenylalanine derivatives as alpha 4 integrin inhibitors | Human Necessities | 15 | Expired |
| US7005433B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6911439B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6489300B1 | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 13 | Expired |
| US7378529B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7427628B2 | Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins | Chemistry; Metallurgy | 13 | Active |
| US10590090B2 | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors | Chemistry; Metallurgy | 12 | Active |
| US6794506B2 | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 10 | Expired |
| US5858982A | Cathepsin and methods and compositions for inhibition thereof | Human Necessities | 10 | Expired |
| US7335663B2 | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins | Human Necessities | 10 | Expired |
| US6953802B2 | Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 9 | Expired |
| US6586602B2 | Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 8 | Expired |
| US6900179B2 | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 8 | Expired |
| US6291453A | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 8 | Expired |
| US7576101B2 | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents | Chemistry; Metallurgy | 8 | Expired |
| US5849711A | Cathepsin and methods and compositions for inhibition thereof | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.